Among proteins specific for this single-stranded
overhang, Pot1 proteins provide the most widespread solution to
chromosome end-capping in eukaryotes. Previous biochemical work
by the group showed that the N-terminal DNA-binding domain Pot1pN
in the fission yeast Schizosaccharomyces pombe, a popular
model organism, had a sequence similarity to the first OB (oligonucleotide/oligosaccharide
binding) fold of the α subunit of the telomere end-binding
protein of the ciliated protozoan Oxytricha nova. However,
without any structural information, the molecular basis for the
DNA-binding specificity that ensures that Pot1 only binds to single-stranded
G-rich telomeric DNA (ssDNA) was not revealed.
To explore the molecular mechanism of this binding specificity,
the researchers crystallized Pot1pN in three different forms in
complex with either the pentanucleotide GGTTA or the hexanucleotide
GGTTAC. From data obtained at ALS Beamlines 8.2.1 and 8.2.2, they
solved the structure of one Pot1pN–GGTTA crystal form by means of
single-wavelength anomalous dispersion (SAD) and refined the structure
to a resolution of 1.9 Å. Then they determined the structures
of the other two crystal forms by molecular replacement (MR) and
a searching model without the ssDNA. They found that the structures
were essentially identical in all three crystal forms.
SsDNA self-recognition by G-T base pairing interactions and binding
with the protein. Owing to the ssDNA intramolecular hydrogen bonds
(dotted yellow lines), the donor/acceptor groups of the
bases face the inner side of the binding groove, thus encouraging
extensive intermolecular hydrogen bonding interactions with the
protein (dotted green lines).
The crystal structure shows that Pot1pN consists of a compact
single domain, the OB fold, comprising a highly curved, five-stranded,
antiparallel β barrel, as implied by the sequence alignment. The
single-stranded DNA binds in a basic concave groove, a characteristic
of OB-fold proteins, formed by one side of the β barrel and two
protruding loops.
More important, the structure explains the exceptionally high sequence
specificity of protein binding. An unanticipated ssDNA-self recognition
involving novel G-T base pairing compacts the DNA, and this folded
DNA structure is bound by the protein through stacking and hydrogen
bonding. Any base sequence change would disrupt the ability of the
DNA to fold into this structure, thus preventing it from contacting
the array of protein hydrogen-bonding groups. Mutational analysis
established the in vivo biological importance of the Pot1–ssDNA
interaction by showing that two residues that were already implicated
by the structure in DNA binding are also important for telomere
maintenance and cell survival.
The in vivo biological importance of the Pot1–ssDNA interaction.
Mutational analysis of residues important for the interaction
of Pot1pN (blue) and ssDNA (yellow) showed that
the red mutations, T62V and F88A, already implicated by the structure
in DNA binding, are also important for telomere maintenance and
cell survival. The mutated residues are shown as green and red
ball-and-stick models.
The structure will serve as a framework for understanding telomere
functions at the molecular level. These functions include Pot1 protein's
essential role in chromosome end-capping in S. pombe, its
contribution to regulation of telomerase in human cells, and its
proposed role in switching telomeres between the protective t-loop
and an open structure accessible to telomerase during replication.
Research conducted by M. Lei, E.R. Podell, and T.R. Cech (University
of Colorado) and P. Baumann (Stowers Institute for Medical Research).
Research funding: The National Institutes of Health, the Stowers
Institute for Medical Research, and the Helen Hay Whitney Foundation.
Operation of the ALS is supported by the U.S. Department of Energy,
Office of Basic Energy Sciences.
Publication about this research: M. Lei, E.R. Podell, P. Baumann,
and T.R. Cech, "DNA self-recognition in the structure of Pot1
bound to telomeric single-stranded DNA," Nature 426,
198 (2003).
ALSNews
Vol. 240, April 28, 2004
|